Matrix metaloproteinase-2 and-9 serum levels as potential markers of intraperitoneal adhesions

Journal of Investigative Surgery

Volumn 26, Issue 3, 2013, Pages 134-140

  Christodoulidis, Gregory ^a   Tsilioni, Irene ^a   Spyridakis, Michail Evangelos ^a   Kiropoulos, Theodoros ^a   Oikonomidi, Smaragda ^a   Koukoulis, George ^a   Tepetes, Konstantinos ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Dimetindene maleate; Icodextrin 4 ; Intraperitoneal adhesions; Matrix metalloproteinases 2 and 9; Prognostic markers

Indexed keywords

DIMETINDENE; GELATINASE A; GELATINASE B; ICODEXTRIN; METALLOPROTEINASE; BIOLOGICAL MARKER; GLUCAN; GLUCOSE;

ADHESION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EUTHANASIA; FEMALE; LAPAROTOMY; MORBIDITY; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL; RABBIT; SENSITIVITY AND SPECIFICITY; TISSUE ADHESION; ANIMAL; BLOOD; PATHOLOGY; PERITONEAL DISEASES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TISSUE ADHESIONS;

ANIMALS; BIOLOGICAL MARKERS; DIMETHINDENE; FEMALE; GLUCANS; GLUCOSE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PERITONEAL DISEASES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RABBITS; TISSUE ADHESIONS;

EID: 84877686949     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2012.730599     Document Type: Article

References (32)

1. Menzies D, Ellis H. Intestinal obstruction from adhesions: how big is the problem? Ann R Coll Surg Eng. 1990;72:60-63. (Pubitemid 20076105)
2. Menzies D. Peritoneal adhesions: incidence, cause and prevention. Surg Ann. 1992;24:27-45.
3. Canis M, Botchorishvili R, Wattiez A, et al. Prevention of peritoneal adherences. Eur J Obstet & Gynecol & Reprod Biol. 2001;30:305-324. (Pubitemid 32601088)
4. Roman H, Canis M, Kamble M, et al. Efficacy of three adhesion-preventing agents in reducing severe peritoneal trauma induced by bipolar coagulation in a laparoscopic rat model. Fertil Steril. 2005;83:1113-1118. (Pubitemid 40543494)
5. Cheong YC, Li TC, Laird SM, et al. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 2001;7:556-566. (Pubitemid 33069614)
6. Burns JW, SkinnerK, ColtMJ, et al.Ahyaluronate based gel for the prevention of post surgical adhesions: evaluation in two animal species. Fertil Steril. 1996;66:814-821. (Pubitemid 26357588)
7. Holtz G. Prevention of postoperative adhesions. J Reprod Med. 1980;24:141-146. (Pubitemid 10101724)
8. Gomel V, Urman B, Gurgan T. Pathophysiology of adhesion formation and strategies for prevention. J Reprod Med. 1996;41:35-41. (Pubitemid 26037954)
9. Parks WC. Matrix metalloproteinases in repair. Wound Rep Regen. 1999;7:423-432. (Pubitemid 30027564)
10. Parsons SL, Watson SA, Brown PD, et al. Matrix metalloproteinases. Br J Surg. 1997;84:160-166. (Pubitemid 27073454)
11. LeeMH, Murphy G. Matrix metalloproteinases at a glance. J Cell Sci. 2004;117:4015-4016. (Pubitemid 39328289)
12. VaalamoM, Leivo T, Saarialho-Kere U, et al.Differential expression of tissue inhibitors of metalloproteinases (TIMP-1,-2,-3,-4) in normal and aberrant wound healing. Hum Path. 1999;30:795-802. (Pubitemid 29325786)
13. Marshall BC, Santana A, Xu Q, Peterson MJ, et al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells cellular differentiation influences expression. J Clin Invest. 1993;91:1792-1799. (Pubitemid 23127386)
14. Martin J, Yung S, Robson RL, et al. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Peri Dial Int. 2000; 20:524-533.
15. Basset P, Okada A, Chenard M.-P, et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 1997;15:535-541. (Pubitemid 27190028)
16. Murphy, G, Knauper, V. Relating matrix metalloproteinase structure to function:why the 'hemopexin' domain? Matrix Biol. 1997;15:511-518. (Pubitemid 27190025)
17. Zuhlke HV, Lorenz EM, Straub EM, et al. Pathophysiology and classification of adhesions. Langenbecks Arch Chir Suppl II 1990;1009-1016.
18. Folley-Corner AJ, Herrick SE, Al-Mishlab T, et al. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. JCell Sci. 2002;115:1383-1389. (Pubitemid 34428696)
19. Bittinger F, Schepp C, Brochhausen C, et al. Remodelling of peritoneal-like structures by mesothelial cells: its role in peritoneal healing. J Surg Res. 1999;82:28-33. (Pubitemid 29394149)
20. Hermanowicz A, Debek W, Oksiuta M, et al. Peritoneal cell response during adhesion formation. J Invest Surg. 2010;23(5):267-272.
21. Greenawalt KE, Colt MJ, Corazzini RL, et al. Remote efficacy for two different forms of hyaluronate-based adhesion barriers. J Invest Surg. 2012;25(3):174-180.
22. Stamenkovic I. Extracellularmatrix remodelling: the role of matrix metalloproteinases J Pathol. 2003;200:448-464. (Pubitemid 36818245)
23. Klein SA, Anderson GL, Kennedy AB, et al. The effects of a broad-spectrum matrixmetalloproteinase inhibitor on characteristics of wound healing. J Invest Surg. 2002;15(4):199-207. (Pubitemid 34960073)
24. Martin J, Yung S, Robson RL, et al. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Peri Dial Int. 2000;20:524-533.
25. Chegini N, Kotseos K, Zhao Y, et al. Expression of matrix metalloproteinases and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions. Fertil Steril. 2001;76:1214-1221.
26. Carolien AM, Koks MD, Groothuis PG, et al. Matrix metalloproteinases and their tissue inhibitors in antegradely hed menstruum and peritoneal fluid. Fertil Steril. 2000; 73:604-612. (Pubitemid 30109663)
27. Cheong YC, Shelton JB, Laird SM, et al. Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta in women with pelvic adhesions. Fertil Steril. 2003;79:1168-1175. (Pubitemid 36547856)
28. Mirastscijski U, Johannesson K, Jeppsson B, et al. Effect of matrix metalloproteinase activity and TNF-alpha converting enzyme inhibitor on intra-abdominal adhesions. Eur Surg Res. 2005;37:68-75. (Pubitemid 40591455)
29. Diamond MP, El-Hammady E, Wang R, et al. Regulation of matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 by Dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Fertil Steril. 2003;81:185-190.
30. Agren MS, Jorgensen LN, Andersen M, et al. Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans. Br J Surg. 1998;85:715-717.
31. Westermarck J, Kahari V-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13:781-792. (Pubitemid 29220691)
32. Cheong YC, Laird SM, Shelton JB, et al. The concentration of IL-1,IL-6 and TNF-alpha in the peritoneal fluid of women with pelvic adhesions. Hum Reprod. 2001;17:69-75.